1-Minute Consult

Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?

Zain Moosvi, MD, Alexander Abadir, MD, Jacqueline Duong, BS and Douglas Nguyen, MD
Cleveland Clinic Journal of Medicine June 2020, 87 (6) 343-346; DOI: https://doi.org/10.3949/ccjm.87a.19071

Article Information

vol. 87 no. 6 343-346
DOI 
https://doi.org/10.3949/ccjm.87a.19071
PubMed 
32487554
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online June 2, 2020.
Copyright & Usage 
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Zain Moosvi, MD⇑
  1. Department of Internal Medicine, University of California Irvine, Orange, CA
  1. Address: Zain Moosvi, MD, Department of Internal Medicine, University of California Irvine, 101 The City Drive S, Orange, CA 92868; zmoosvi{at}uci.edu
  1. Alexander Abadir, MD
  1. Department of Internal Medicine, University of California Irvine, Orange, CA
  1. Jacqueline Duong, BS
  1. University of California, Irvine
  1. Douglas Nguyen, MD
  1. Department of Gastroenterology and Hepatology, University of California Irvine, Orange, CA

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects